Director General Of NAFDAC Orders Manufacturing of Chloroquine for Emergency Stock for Possible Clinical Trial Treatment of Coronavirus (2019-nCoV)
, Chloroquine, an old antimalarial is being repurposed for the clinical trial treatment of Coronavirus 2019-nCoV. The drug was first tested in vitro (in the lab) using standard assays to measure the effects on the cytotoxicity, virus yield and infection rates of 2019-nCoV. The drug was reported to function as antiviral at both the entry […]